New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Omrix Biopharmaceuticals (OMRI)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
Topic Listing for Omrix Biopharmaceuticals
Additional Conversion Common Stock Following Recapitalization
Agreement Price
Amendments Articles Incorporation Bylaws Change
Ana Stancic
Annual Cash Bonus Awards
Annual Report
Appointment Evaluation Oversight Independent Auditors Audit Process
Approval Proposals
Audit Committee
Audit Committee Charter
Base Salary
Basis Ceo Performance Evaluation
Beneficial Ownership Reporting Compliance
Benefits
Board Audit Committee Recommend Stockholders
Board Committees
Board Meeting Attendance Directors Other Matters
Board Recommends Stockholders
Board Recommends Stockholders Vote
Certain Relationships Related Party Transactions
Change Vote Revoke Proxy After Mailed Card
Changes Disagreements Accountants Accounting Financial Disclosure
Code Ethics
Common Stock Warrants Options Outstanding Prior Recapitalization
Compensation Committee
Compensation Committee Interlocks Insider Participation
Compensation Committee Report
Compensation Program Objectives
Composition Board
Conversion Series Convertible Preferred Stock Common
Corporate Governance
Corporate Governance Guidelines
Departure Directors Certain Officers Election Appointment Compensatory
Did Receive Proxy Card
Director Compensation
Director Independence
Employment Agreements Named Executive Officers
Employment Severance Agreements Named Executive Officers
Entry Material Definitive Agreement
Equity Incentive Plans
Executive Compensation
Expenses Solicitation
Fees Independent Registered Public Accounting Firm
Financial Statements Exhibits
Governance Nominating Committee
Grants Plan-based Awards 2006
Harold Safferstein
Held 2007
Held 2008
Householding Proxy Materials
Investor Rights Agreement
Involuntary Termination Without Cause
Involuntary Termination Without Cause Voluntary Good Reason
Limit Deductibility Executive Compensation
Long-term Incentives
Marc Droppert
Membership Committee
Michael Burshtine
Nanci Prado
New Convertible Promissory Notes
Nissim Mashiach
Nominations Directors
Non-qualified Deferred Compensation
Options Exercises Stock Vested 2006
Options Exercises Stock Vested 2007
Other Events
Other Executive Officers
Other Matters
Other Relationships
Oversight Financial Reporting Internal Controls
Pays Cost Proxy Solicitation
Pension Benefits 2006 End
Pension Benefits 2007 End
Perquisites
Potential Payments Termination Change Control Employment Agreements
Procedures
Proxy Statement
Proxy Statement Only Way Proxies Being Solicited
Qualified Vote
Quorum
Ratification Appointment Kost Forer Gabbay Kasierer Member Ernst
Recapitalization
Regulation Disclosure
Report Audit Committee
Results Operations Financial Condition
Robert Taub
Role Compensation Consultant
Shares Common Stock Vote Meeting
Shares Voted Not Specify They
Signatures
Special Cash Bonus Award
Special Cash Bonus Awards
Stock Price Performance Graph
Stockholder Communications Board
Stockholder Proposals 2008 Annual Meeting Stockholders
Table Contents
Termination Cause Without Good Reason
Termination Cause Without Reason
Termination Change Control
Termination Change Control Arrangements
Termination Due Death Disability
Top Form
Vote Shares
Vote Shares Person Meeting
Votes Withheld Abstentions Broker Non-votes Treated
What Boards Recommendations Vote Shares
What Choices Voting
What Difference Between Stockholder Record Street Name Holder
What Proxy
What Vote Required Approve Each Proposal
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour